| Sheena Lou-lu Bruenn, NURSE PRACTITIONER | |
|
155 Main St, Brewster, NY 10509-1521 | |
| (845) 279-6999 | |
| Not Available |
| Full Name | Sheena Lou-lu Bruenn |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 155 Main St, Brewster, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760913768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | 341479 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sheena Lou-lu Bruenn, NURSE PRACTITIONER 66 Morningside Dr, Patterson, NY 12563-2308 Ph: (845) 721-0822 | Sheena Lou-lu Bruenn, NURSE PRACTITIONER 155 Main St, Brewster, NY 10509-1521 Ph: (845) 279-6999 |
News Archive
A team of scientific experts from across the U.S. and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade's worth of disparities.
As President Obama on Monday met with health care industry groups regarding their pledge to reduce $2 trillion in expected health care spending increases over the next 10 years, many health care advocates expressed skepticism about the promise, the Hartford Courant reports (Levick, Hartford Courant, 5/12).
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.
Seriously ill patients undergoing hemodialysis are more optimistic about their prognosis and prospects for transplants than their nephrologists, according to a study published online by JAMA Internal Medicine.
In the first study, French scientists looked at neonatal outcome in terms of mode of delivery, gestational age, preterm birth rate (less than 37 weeks of gestation), mean child measurements, low birth weight (less than 2,500g) and perinatal mortality. When comparing the cryo singletons to the fresh cohort, the scientists showed that mean birth weight, mean height and head circumference were lower in the fresh population.
› Verified 9 days ago